Prior to joining Lassen, Cadmus served as Chief Medical Officer and Head of R&D for Aura Biosciences, an oncology company developing first in class oncology treatments for primary tumors to reduce the incidence of metastatic cancer, starting with the lead indication in choroidal melanoma and a secondary indication in non-muscle invasive bladder cancer. Prior to Aura, Cadmus has held progressive positions in Ophthalmology R&D including Medical Director/Senior Director at Quintiles, Head of Clinical Trial Management at Alcon, Therapeutic Unit Head for Intraocular Lens R&D at Alcon and VP, Clinical Development and Medical Affairs for Inotek Pharmaceuticals. In these roles he actively participated in the product development of over 40 Drugs/Devices (including the approval of 5 drugs and 5 devices in the US and other global regions) and has led or participated in over 125 clinical trials.
Cadmus received his MD and Ophthalmology training at UNC Medical School/UNC Hospitals, his BA in Psychology from Case Western Reserve University, and his MBA in Health Care Administration from Regis University. Prior to joining the Research and Development industry, Cadmus practiced cataract/refractive surgery and comprehensive ophthalmology and served as a Principal Investigator in multiple clinical trials. His passion is to combine his experience in ophthalmology, leadership, business and research and development to meet unmet medical needs for patients and coaching and mentoring professionals.